Literature DB >> 11727824

Protein-DNA interaction and CpG methylation at rep*/vIL-10p of latent Epstein-Barr virus genomes in lymphoid cell lines.

H H Niller1, D Salamon, M Takacs, J Uhlig, H Wolf, J Minarovits.   

Abstract

The viral interleukin-10 promoter (vIL-10p), overlapping the rep* element in the Epstein-Barr virus (EBV) genome, is a promoter element active mostly in the late phase of the lytic cycle and immediately upon infection of B cells. rep* was, through transfection experiments with small plasmids, characterised as a cis element supporting oriP replicative function. In this study, in vivo protein binding and CpG methylation at rep*/vIL-10p were analysed in five cell lines that harbour strictly latent EBV genomes. Contrary to the invariably unmethylated dyad symmetry element (DS) of oriP, rep*/vIL-10p was highly methylated and showed only traces of protein binding in all examined cell lines. This result is in agreement with vIL-10p being an inactive promoter of EBV genomes, and makes it less likely that rep* functions as a replicative element of latent EBV genomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727824     DOI: 10.1515/BC.2001.174

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  6 in total

1.  Nucleoprotein structure of immediate-early promoters Zp and Rp and of oriLyt of latent Epstein-Barr virus genomes.

Authors:  Hans Helmut Niller; Daniel Salamon; Jörg Uhlig; Stefanie Ranf; Marcus Granz; Fritz Schwarzmann; Hans Wolf; Janos Minarovits
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 2.  Cytokine homologs of human gammaherpesviruses.

Authors:  Sang-Hoon Sin; Dirk P Dittmer
Journal:  J Interferon Cytokine Res       Date:  2011-12-05       Impact factor: 2.607

3.  High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.

Authors:  Agnes Bakos; Ferenc Banati; Anita Koroknai; Maria Takacs; Daniel Salamon; Susanna Minarovits-Kormuta; Fritz Schwarzmann; Hans Wolf; Hans Helmut Niller; Janos Minarovits
Journal:  Virus Genes       Date:  2007-05-18       Impact factor: 2.332

4.  Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.

Authors:  Charles M Chau; Xiao-Yong Zhang; Steven B McMahon; Paul M Lieberman
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes.

Authors:  Daniel Salamon; Maria Takacs; Fritz Schwarzmann; Hans Wolf; Janos Minarovits; Hans Helmut Niller
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

6.  The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates.

Authors:  Kyosuke Kanai; Yukio Satoh; Hiroyuki Yamanaka; Asako Kawaguchi; Kazutaka Horie; Kenji Sugata; Yoshiko Hoshikawa; Tetsutaro Sata; Takeshi Sairenji
Journal:  Virus Genes       Date:  2007-08-31       Impact factor: 2.198

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.